换一批Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
第一作者：
Ashley,Weir
第一单位：
School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, NSW, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia.;The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
作者：
Ashley,Weir [1]
;
Eun-Young,Kang [2]
;
Nicola S,Meagher [3]
;
Gregg S,Nelson [4]
;
Prafull,Ghatage [4]
;
Cheng-Han,Lee [5]
;
Marjorie J,Riggan [6]
;
Aleksandra,Gentry-Maharaj [7]
;
Andy,Ryan [8]
;
Naveena,Singh [9]
;
Martin,Widschwendter [10]
;
Jennifer,Alsop [11]
;
Michael S,Anglesio [12]
;
Matthias W,Beckmann [13]
;
Jessica,Berger [14]
;
Christiani,Bisinotto [15]
;
Jessica,Boros [16]
;
Alison H,Brand [17]
;
James D,Brenton [18]
;
Angela,Brooks-Wilson [19]
;
Michael E,Carney [20]
;
Julie M,Cunningham [21]
;
Kara L,Cushing-Haugen [22]
;
Cezary,Cybulski [23]
;
Esther,Elishaev [24]
;
Ramona,Erber [25]
;
Sian,Fereday [26]
;
Anna,Fischer [27]
;
Luis,Paz-Ares [28]
;
Javier,Gayarre [29]
;
Blake C,Gilks [30]
;
Marcel,Grube [31]
;
Paul R,Harnett [32]
;
Holly R,Harris [33]
;
Arndt,Hartmann [25]
;
Alexander,Hein [13]
;
Joy,Hendley [34]
;
Brenda Y,Hernandez [35]
;
Sabine,Heublein [36]
;
Yajue,Huang [21]
;
Tomasz,Huzarski [37]
;
Anna,Jakubowska [38]
;
Mercedes,Jimenez-Linan [39]
;
Catherine J,Kennedy [16]
;
Felix K F,Kommoss [40]
;
Jennifer M,Koziak [41]
;
Bernhard,Kraemer [31]
;
Nhu D,Le [42]
;
Jaime,Lesnock [14]
;
Jenny,Lester [43]
;
Jan,Lubiński [23]
;
Janusz,Menkiszak [44]
;
Britta,Ney [27]
;
Alexander,Olawaiye [14]
;
Sandra,Orsulic [43]
;
Ana,Osorio [45]
;
Luis,Robles-Díaz [46]
;
Matthias,Ruebner [13]
;
Mitul,Shah [11]
;
Raghwa,Sharma [47]
;
Yurii B,Shvetsov [35]
;
Helen,Steed [48]
;
Aline,Talhouk [12]
;
Sarah E,Taylor [14]
;
Nadia,Traficante [26]
;
Robert A,Vierkant [49]
;
Chen,Wang [50]
;
Lynne R,Wilkens [35]
;
Stacey J,Winham [50]
;
Javier,Benitez [45]
;
Andrew,Berchuck [6]
;
David D,Bowtell [26]
;
Francisco J,Candido Dos Reis [15]
;
Linda S,Cook [51]
;
Anna,DeFazio [52]
;
AOCs group [53]
;
Jennifer A,Doherty [13]
;
Peter A,Fasching [54]
;
María J,García [55]
;
Ellen L,Goode [56]
;
Marc T,Goodman [23]
;
Jacek,Gronwald [57]
;
David G,Huntsman [43]
;
Beth Y,Karlan [31]
;
Stefan,Kommoss [58]
;
Francesmary,Modugno [59]
;
Joellen M,Schildkraut [40]
;
Hans-Peter,Sinn [27]
;
Annette,Staebler [60]
;
Linda E,Kelemen [61]
;
Caroline E,Ford [7]
;
Usha,Menon [62]
;
Paul D P,Pharoah [2]
;
Martin,Köbel [63]
;
Susan J,Ramus
作者单位：
School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, NSW, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia.;The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
[1]
Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
[2]
School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, NSW, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia.;The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
[3]
Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
[4]
Department of Pathology and Laboratory Medicine, University of Alberta, Edmonton, AB, Canada.
[5]
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA.
[6]
MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
[7]
MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.;Women's Cancer, Institute for Women's Health, University College London, London, UK.
[8]
Department of Pathology, Barts Health National Health Service Trust, London, UK.
[9]
EUTOPS Institute, University of Innsbruck, Innsbruck, Austria.
[10]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
[11]
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.;British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada.
[12]
Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
[13]
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
[14]
Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
[15]
Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia.;The University of Sydney, Sydney, NSW, Australia.
[16]
Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia.;The University of Sydney, Sydney, NSW, Australia.
[17]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
[18]
Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
[19]
Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
[20]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
[21]
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[22]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
[23]
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
[24]
Institute of Pathology, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
[25]
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
[26]
Institute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany.
[27]
H12O-CNIO Lung Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.;Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
[28]
Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[29]
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
[30]
Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
[31]
The University of Sydney, Sydney, NSW, Australia.;Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.
[32]
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.;Department of Epidemiology, University of Washington, Seattle, WA, USA.
[33]
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[34]
University of Hawaii Cancer Center, Honolulu, HI, USA.
[35]
Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany.
[36]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.;Department of Genetics and Pathology, University of Zielona Gora, Zielona Gora, Poland.
[37]
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.;Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland.
[38]
Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.
[39]
Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
[40]
Alberta Health Services-Cancer Care, Calgary, AB, Canada.
[41]
Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
[42]
David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA.
[43]
Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.
[44]
Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.;Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
[45]
Familial Cancer Unit and Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
[46]
Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, NSW, Australia.
[47]
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alberta, Edmonton, AB, Canada.;Section of Gynecologic Oncology Surgery, North Zone, Alberta Health Services, Edmonton, AB, Canada.
[48]
Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
[49]
Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA.
[50]
Epidemiology, School of Public Health, University of Colorado, Aurora, CO, USA.;Community Health Sciences, University of Calgary, Calgary, AB, Canada.
[51]
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.;Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.;Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia.;The University of Sydney, Sydney, NSW, Australia.
[52]
Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
[53]
Computational Oncology Group, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[54]
Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
[55]
Cancer Prevention and Control Program, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
[56]
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.;Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.
[57]
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.;Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.;Women's Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA.
[58]
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
[59]
Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
[60]
School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, NSW, Australia.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia.;School of Women's and Children's Health, Faculty of Medicine and Health, University of NSW Sydney, Sydney, NSW, Australia.
[61]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
[62]
School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, NSW, Australia. s.ramus@unsw.edu.au.;Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, NSW, Australia. s.ramus@unsw.edu.au.
[63]
医学主题词
人类(Humans);女(雌)性(Female);卵巢肿瘤(Ovarian Neoplasms);预后(Prognosis);存活率分析(Survival Analysis);RNA, 信使(RNA, Messenger);囊腺癌, 浆液(Cystadenocarcinoma, Serous);叉头转录因子类(Forkhead Transcription Factors)
DOI
10.1038/s41416-022-02014-y
PMID
36323878
发布时间
2025-06-23
- 浏览4
British journal of cancer
British journal of cancer
137-147页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
